NSE · AI Signal & Stock Analysis · Bullish
As of Oct 14 2026, 6:52 PM, AkshayaAI's signal for SYMBIOTEC is Bullish ↑ (extreme move); technical trend down-trend; trading at ₹1,253.20 (+6.84% today); neutral (RSI 64).
Data as of Oct 14 2026, 6:52 PM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bullish ↑ · Extreme move |
|---|---|
| Technical trend | Down-trend (since 2026-09-01) |
| Price | ₹1,253.20 |
| Change today | +6.84% |
| RSI (14) | 64.40 |
| Relative volume | 0.94 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹8,053 Cr |
| P/E | 85.66 |
| Cap category | Mid Cap |
| 52-week high | 0.0% away |
| 52-week low | +24.9% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - General |
As of Oct 14 2026, 6:52 PM, AkshayaAI's signal for SYMBIOTEC (SYMBIOTEC PHARMALAB LTD) is Bullish with a extreme move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
SYMBIOTEC's RSI is neutral (RSI 64). A reading above 70 is typically overbought and below 30 oversold.
SYMBIOTEC is trading about 0% below its 52-week high and 25% above its 52-week low as of Oct 14 2026, 6:52 PM.
SYMBIOTEC's market capitalisation is ₹8,053 Cr as of Oct 14 2026, 6:52 PM.
SYMBIOTEC is classified under Drug Manufacturers - General in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for SYMBIOTEC — not personalised investment advice. Always do your own research.
GLAXO · MARKSANS · PFIZER · RUBICON · SANOFI · SANOFICONR
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Oct 14 2026, 6:52 PM and may not reflect real-time prices. Always do your own research. How these signals work →